| Application no. and date | 00107100.0 (espacenet) (Federated) (European Patent Register), 20000406 | | Patent/reg. no. and date | DK/EP 1043025, 20050601 | | Publication date | 20001011 | | Priority no. and date | US 288359, 19990408 | | EP pub. no. and date |
EP 1043025 20001011 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue
Rayway, New Jersey 07065, US | | Applicant ref. no. | 109404 | | Inventor | Rybak, Mary Ellen, 5 Chesterfield Drive
Warren, NJ 07059, US,
Rose, Esther Helen, 755 Belvidere Avenue
Westfield, NJ 07090, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 38/21 (2006.01) , A61K 47/48 (2006.01) , A61P 35/00 (2006.01) | | Title | Behandling af nyrecellekarcinom | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
